Diagnosis of IBD involves long-term follow-up to infectious respiratory digestive and endocrine disorders, clinical performance is complex and often involves multi-systematic stress. Early identification and standardized diagnosis are critical to improving prognosis. Diagnosis of IBD involves a combination of clinical performance, imaging, laboratory testing and pathological evaluation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored throughout the treatment process, and timely adjusted according to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of long-term follow-up of IBD. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.